Piramal Phytocare

Piramal Phytocare, formerly known as Piramal Life Sciences, was an Indian pharmaceutical company dedicated to the development and global commercialization of phytopharmaceuticals and natural healthcare products. The company specialized in bridging traditional herbal medicine with modern scientific validation, focusing on chronic lifestyle ailments such as diabetes, inflammation, and hepatic disorders. Its research engine was built on a vast library of plant extracts and a history of New Chemical Entity (NCE) discovery. Piramal Phytocare maintained a portfolio of both prescription and over-the-counter products aimed at improving quality of life through natural alternatives. In 2018, the company was merged into its parent organization, Piramal Enterprises Limited, to streamline the group's healthcare operations and consolidate its pharmaceutical business.